Company / Free Cash Flow per Share
Voyager Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.36
FY2025
5-year range
-$2.87 / $1.36
FY2021-FY2025
Trend
+500.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed +501% YoY in FY2025, a notable deviation from the 9-year average annual change of +86%.
Based on SEC 10-K filings.
1.36 in FY2025.
Improved from $-1.43 to $1.36 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Voyager Therapeutics, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 500.5% year-over-year.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.36 | +500.5% |
| FY2024 | -$0.34 | +76.1% |
| FY2023 | -$1.43 | +50.2% |
| FY2022 | -$2.87 | -361.9% |
| FY2021 | $1.10 | +300.1% |
| FY2020 | -$0.55 | +72.9% |
| FY2019 | -$2.02 | -34.1% |
| FY2018 | -$1.50 | -195.7% |
| FY2017 | $1.57 | +363.1% |
| FY2016 | -$0.60 | +91.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026